NCT02148029

Brief Summary

Despite standard care, 25%-50% of patients with clots in the deep veins of the arms and legs progress to chronic post-clot problems resulting in significant disability, loss of productivity, and healthcare costs. Reverse flow in the veins from an organizing clot is the primary cause of post-clot problems. Veins with early clot breakdown have a lower incidence of reverse flow. The investigators have observed that clot breakdown is enhanced by increased blood flow and that moderate arm and leg exercise result in increased venous blood flow. Hence, the investigators predict that a supervised exercise program in patients with deep vein clots could increase leg vein blood flow, accelerate clot breakdown, and decrease the risk of post clot problems. The primary hypothesis is that increased blood flow across the clot (induced by supervised exercise) will increase clot breakdown and decrease severity of post clot problems. The investigators are conducting a randomized clinical trial of standard therapy compared to progressive exercise training in patients with leg deep vein clots.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
107

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2014

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 21, 2014

Completed
7 days until next milestone

First Posted

Study publicly available on registry

May 28, 2014

Completed
4 months until next milestone

Study Start

First participant enrolled

September 15, 2014

Completed
7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2021

Completed
3.1 years until next milestone

Results Posted

Study results publicly available

October 23, 2024

Completed
Last Updated

October 23, 2024

Status Verified

October 1, 2024

Enrollment Period

7 years

First QC Date

May 21, 2014

Results QC Date

February 15, 2024

Last Update Submit

October 21, 2024

Conditions

Keywords

Deep vein thrombosisPost thrombotic syndromeThrombus resolution

Outcome Measures

Primary Outcomes (2)

  • 2-year Change in Villalta Score

    The Villalta score quantifies severity of symptoms and can be used to diagnose Post-Thrombotic Syndrome (PTS). The Villalta score quantifies severity of symptoms and can be used to diagnose Post-Thrombotic Syndrome (PTS). Higher Villalta scores denote more severe symptoms and greater likelihood of PTS. The outcome measure is not the score itself, but change in scores over time, calculated by subtracting the baseline score from the score at the 2-year follow-up. The range of the Villalta score is 0-33, so the minimum possible change is -33 and the maximum possible change is 33, with 0 indicating no change in Villalta scores (same score at baseline and at 2-year follow-up). An increase (positive change) in Villalta score indicates worsening symptoms, while a decrease (negative change) indicates improving symptoms.

    Change from baseline to 2-year follow-up

  • 2-year Change in VEINES-QOL Summary Score

    The VEINES-QOL summary score is calculated from the Venous Insufficiency Epidemiological and Economic Study (VEINES) Quality of Life (QOL) questionnaire, and it provides an estimate of the overall impact of deep venous thrombosis (DVT) on the patient's quality of life. A higher VEINES-QOL score indicates better quality of life. The outcome measure is not the score itself, but change in scores over time, calculated by subtracting the baseline score from the score at the 2-year visit. The range of the VEINES-QOL summary score is 25-117, so the minimum possible change is -92 and the maximum possible change is 92, with 0 indicating no change in VEINES-QOL scores (same score at baseline and at 2-year follow-up). An increase (positive change) in VEINES-QOL score indicates an improvement in quality of life, and a decrease (negative change) indicates worsening quality of life.

    Change from baseline to 2-year follow-up

Secondary Outcomes (2)

  • 2-year Change in SF-36 Domain Scores

    Change from baseline to 2-year follow-up

  • 3-month Percent-change in Thrombus Volume

    Change from baseline to 3-month follow-up

Study Arms (2)

Control

ACTIVE COMPARATOR

Standard care: anticoagulation, compression, and ad-lib ambulation

Other: Standard Care

Exercise

EXPERIMENTAL

Standard care + Interventional Exercise therapy

Other: ExerciseOther: Standard Care

Interventions

Upper and Lower extremity exercise

Exercise

anticoagulation, compression, and ad-lib ambulation

ControlExercise

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Acute Lower Extremity DVT
  • DVT documented by ultrasound, CT/Magnetic Resonance imaging (MR) venogram, or conventional venogram
  • Enrolled within 4 weeks of onset of symptoms
  • Age 18 years or older

You may not qualify if:

  • Peripheral arterial disease (disabling claudication, rest pain, tissue loss) with ankle brachial index (ABI)\<0.5
  • Immediate need for thrombolysis/thrombectomy
  • DVT involving the inferior vena cava (IVC)
  • Contraindication to anticoagulation
  • Contraindications to exercise training
  • Medical illness interfering with evaluation/follow-up
  • Life expectancy \<2 years
  • Pregnancy
  • Inability to walk
  • Hemodynamically significant PE

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD

Baltimore, Maryland, 21201, United States

Location

MeSH Terms

Conditions

Venous ThrombosisPostthrombotic Syndrome

Interventions

ExerciseStandard of Care

Condition Hierarchy (Ancestors)

ThrombosisEmbolism and ThrombosisVascular DiseasesCardiovascular DiseasesVenous Insufficiency

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological PhenomenaQuality Indicators, Health CareQuality of Health CareHealth Services AdministrationHealth Care Quality, Access, and Evaluation

Results Point of Contact

Title
Dr. Brajesh K. Lal
Organization
Veterans Administration of Baltimore Maryland

Study Officials

  • Brajesh K Lal, MD

    Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
FED
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 21, 2014

First Posted

May 28, 2014

Study Start

September 15, 2014

Primary Completion

August 31, 2021

Study Completion

August 31, 2021

Last Updated

October 23, 2024

Results First Posted

October 23, 2024

Record last verified: 2024-10

Data Sharing

IPD Sharing
Will not share

Locations